|
Aug, 2009 | Pages : 120 | Price : US$ 1600.00 |
| The Asia-Pacific biotech market is projected to grow at a CAGR of around 14% during 2010-2012. Currently, the industry is driven by new developing markets like Malaysia and India. |
| |
|
Aug, 2009 | Pages : 85 | Price : US$ 1200.00 |
| In 2008, generics accounted for more than 51% prescriptions and around 23% sales of the total pharmaceutical market. |
| |
|
Aug, 2009 | Pages : 90 | Price : US$ 1400.00 |
| The number of diabetic patients in the world is estimated to reach more than 250 Million in 2008. The global insulin market is forecasted to grow at a CAGR of around 15% during 2010-2012. |
| |
|
Jan, 2009 | Pages : 50 | Price : US$ 800.00 |
| Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue. |
| |
|
Dec, 2008 | Pages : 80 | Price : US$ 1100.00 |
| By 2012, it’s expected that more than two billion people will be overweight and 600 Million will be obese, representing immense opportunities for both the markets. |
| |
|
Nov, 2008 | Pages : 60 | Price : US$ 800.00 |
| The Ukraine market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012, despite country’s unstable political environment. |
| |
|
Sep, 2008 | Pages : 100 | Price : US$ 1000.00 |
| Total healthcare spending in the US is expected to grow at a CAGR of 7% (2007-2012). Around 122 Million Americans are expected to spend over US$ 414 Billion on cardiovascular diseases by 2012. |
| |
|
Sep, 2008 | Pages : 115 | Price : US$ 1100.00 |
| The Russian pharmaceutical market grew 16% in 2007 as compared to 2006. The Russian pharmaceutical market is forecasted to grow at a CAGR of 14.36% by 2012. |
| |
|
Aug, 2008 | Pages : 85 | Price : US$ 1600.00 |
| Growing at a CAGR of 12.3% between 2007 and 2012, the global market for cancer drugs is expected to cross US$ 78 Billion by 2012. |
| |
|
Mar, 2008 | Pages : 70 | Price : US$ 1400.00 |
| Indian contract manufacturing market is expected to grow in excess of CAGR 37% between 2007 and 2012. Most companies presently outsource APIs and intermediates from India. |
| |
|
|
